Home
/
Theriva Biologics, Inc.
/
Financials
/
Quarterly
Theriva Biologics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Theriva Biologics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2011
Sep 30, 2011
$293.4K
Nov 14, 2011
Q2
2011
Jun 30, 2011
$355.6K
Aug 15, 2011
Q3
2011
Sep 30, 2010
$289.9K
Nov 14, 2011
Q2
2011
Jun 30, 2010
$2.19M
Aug 15, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
($3.30M)
Nov 13, 2023
Q3
2023
Sep 30, 2022
($4.49M)
Nov 13, 2023
Q2
2022
Jun 30, 2022
($4.97M)
Aug 11, 2022
Q3
2022
Jun 30, 2022
($4.97M)
Nov 10, 2022
Q1
2022
Mar 31, 2022
($4.27M)
May 16, 2022
Q3
2022
Mar 31, 2022
($4.27M)
Nov 10, 2022
Q2
2022
Mar 31, 2022
($4.27M)
Aug 11, 2022
Q3
2022
Sep 30, 2021
($3.27M)
Nov 10, 2022
Q3
2022
Jun 30, 2021
($3.20M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($3.20M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($2.54M)
May 16, 2022
Q2
2022
Mar 31, 2021
($2.54M)
Aug 11, 2022
Q3
2022
Mar 31, 2021
($2.54M)
Nov 10, 2022
Q3
2021
Sep 30, 2020
($2.10M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($2.87M)
Aug 5, 2021
Q3
2021
Jun 30, 2020
($2.87M)
Nov 3, 2021
Q1
2021
Mar 31, 2020
($2.96M)
May 5, 2021
Q2
2021
Mar 31, 2020
($2.96M)
Aug 5, 2021
Q3
2021
Mar 31, 2020
($2.96M)
Nov 3, 2021
Q3
2020
Sep 30, 2019
($5.12M)
Nov 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.44M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($13.13M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($4.42M)
May 14, 2025
Q3
2025
Sep 30, 2024
($7.89M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($8.49M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($5.39M)
May 14, 2025
Q3
2024
Sep 30, 2023
($4.22M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($5.82M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($5.18M)
May 7, 2024
Q3
2023
Sep 30, 2022
($4.99M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($5.03M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($4.25M)
May 11, 2023
Q3
2022
Sep 30, 2021
($3.28M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($3.20M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($2.54M)
May 16, 2022
Q3
2021
Sep 30, 2020
($2.11M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($2.89M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($3.03M)
May 5, 2021
Q3
2020
Sep 30, 2019
($5.24M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($3.64M)
Aug 6, 2020